ID
24479
Beschreibung
Study ID: 100579 Clinical Study ID: 100579 Study Title: Double-blind, randomized study to evaluate the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 6 month schedule in healthy adult subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00289757 https://clinicaltrials.gov/ct2/show/NCT00289757 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A Documentation part: Study Conclusion
Link
https://clinicaltrials.gov/ct2/show/NCT00289757
Stichworte
Versionen (1)
- 02.08.17 02.08.17 -
Hochgeladen am
2. August 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine Study Conclusion 100579
Study Conclusion Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 100579
Beschreibung
Long Term Follow-up
Alias
- UMLS CUI-1
- C1517942
- UMLS CUI-2
- C0170300
Beschreibung
Subject number of previous study
Datentyp
text
Alias
- UMLS CUI [1,1]
- C2348585
- UMLS CUI [1,2]
- C2242969
Beschreibung
Date of birth
Datentyp
date
Alias
- UMLS CUI [1]
- C0421451
Beschreibung
long-term follow-up study participation
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C2348568
- UMLS CUI [1,2]
- C1517942
- UMLS CUI [1,3]
- C0170300
Beschreibung
long-term follow-up study participation
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C2348568
- UMLS CUI [1,2]
- C1517942
- UMLS CUI [1,3]
- C0170300
Beschreibung
Subject eligible but not willing to participate due to
Datentyp
text
Alias
- UMLS CUI [1]
- C0877248
- UMLS CUI [2,1]
- C2348568
- UMLS CUI [2,2]
- C1517942
- UMLS CUI [2,3]
- C0170300
Beschreibung
Subject eligible but not willing to participate due to
Datentyp
text
Alias
- UMLS CUI [1,1]
- C2348568
- UMLS CUI [1,2]
- C1517942
- UMLS CUI [1,3]
- C0170300
Beschreibung
Date of contact
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C1705415
Beschreibung
Investigator signature
Datentyp
text
Alias
- UMLS CUI [1]
- C2346576
Beschreibung
Investigator signature date
Datentyp
date
Alias
- UMLS CUI [1,1]
- C2346576
- UMLS CUI [1,2]
- C0011008
Ähnliche Modelle
Study Conclusion Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 100579
C0008976 (UMLS CUI-2)
C0016441 (UMLS CUI-3)
C0170300 (UMLS CUI-4)
C2348568 (UMLS CUI [1,2])
C0679823 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0558080 (UMLS CUI [2,1])
C0679823 (UMLS CUI [2,2])
C0392360 (UMLS CUI [2,3])
C0679823 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C2242969 (UMLS CUI [1,2])
C1517942 (UMLS CUI [1,2])
C0170300 (UMLS CUI [1,3])
C1517942 (UMLS CUI [1,2])
C0170300 (UMLS CUI [1,3])
C2348568 (UMLS CUI [2,1])
C1517942 (UMLS CUI [2,2])
C0170300 (UMLS CUI [2,3])
C1517942 (UMLS CUI [1,2])
C0170300 (UMLS CUI [1,3])
C1705415 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])